2023 年开放峰会摘要--海报和口头报告

Yasmin Abdul Aziz, Vivian Ng, Diya Srinivasan, Julie Vo, Laura Desveaux, Kevin Schwartz, Z. Rosenberg-Yunger, Erin Berenbaum, Lindsay Friedman, Bradley Langford, Valerie Leung, Emily Angl, Nardine Nakhla, Mina Tadrous, Barbara Farrell, Mathew DeMarco, Nancy Waite, Lisa Dolovich, Mansur Mehdi, Jon Jones, Humayra Tasnim, Mhd Wasem, E. Alsabbagh, Kelly Neiterman, Grindrod, Kristy Scarfone, Shaleesa Ledlie, D. Shearer, Tara Gomes
{"title":"2023 年开放峰会摘要--海报和口头报告","authors":"Yasmin Abdul Aziz, Vivian Ng, Diya Srinivasan, Julie Vo, Laura Desveaux, Kevin Schwartz, Z. Rosenberg-Yunger, Erin Berenbaum, Lindsay Friedman, Bradley Langford, Valerie Leung, Emily Angl, Nardine Nakhla, Mina Tadrous, Barbara Farrell, Mathew DeMarco, Nancy Waite, Lisa Dolovich, Mansur Mehdi, Jon Jones, Humayra Tasnim, Mhd Wasem, E. Alsabbagh, Kelly Neiterman, Grindrod, Kristy Scarfone, Shaleesa Ledlie, D. Shearer, Tara Gomes","doi":"10.1177/17151635231219546","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Expanding pharmacists' scope of practice to include prescribing for thirteen minor ailments, including infectious diseases, in the community pharmacy setting began January 2023. This expansion presents opportunities to improve patients’ access to timely care and harness pharmacists’ expertise to increase appropriate prescribing. Identifying key facilitators and barriers for the effective implementation of pharmacist prescribing is crucial to proactively support this evolution. OBJECTIVE : To identify facilitators and barriers for the effective implementation of pharmacists prescribing medications for selected minor ailments and infectious diseases METHODS : Virtual interviews and online surveys were utilized to gather pharmacists’ perspectives on service provision across Ontario prior to the launch. Virtual focus group discussions were conducted with primary care physicians and patients separately. Focus groups and interviews were audio recorded, transcribed verbatim and thematically analyzed. Data analysis was guided by the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework","PeriodicalId":9476,"journal":{"name":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","volume":"50 ","pages":"S1 - S45"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"OPEN Summit 2023 Abstracts–Poster and Oral Presentations\",\"authors\":\"Yasmin Abdul Aziz, Vivian Ng, Diya Srinivasan, Julie Vo, Laura Desveaux, Kevin Schwartz, Z. Rosenberg-Yunger, Erin Berenbaum, Lindsay Friedman, Bradley Langford, Valerie Leung, Emily Angl, Nardine Nakhla, Mina Tadrous, Barbara Farrell, Mathew DeMarco, Nancy Waite, Lisa Dolovich, Mansur Mehdi, Jon Jones, Humayra Tasnim, Mhd Wasem, E. Alsabbagh, Kelly Neiterman, Grindrod, Kristy Scarfone, Shaleesa Ledlie, D. Shearer, Tara Gomes\",\"doi\":\"10.1177/17151635231219546\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND: Expanding pharmacists' scope of practice to include prescribing for thirteen minor ailments, including infectious diseases, in the community pharmacy setting began January 2023. This expansion presents opportunities to improve patients’ access to timely care and harness pharmacists’ expertise to increase appropriate prescribing. Identifying key facilitators and barriers for the effective implementation of pharmacist prescribing is crucial to proactively support this evolution. OBJECTIVE : To identify facilitators and barriers for the effective implementation of pharmacists prescribing medications for selected minor ailments and infectious diseases METHODS : Virtual interviews and online surveys were utilized to gather pharmacists’ perspectives on service provision across Ontario prior to the launch. Virtual focus group discussions were conducted with primary care physicians and patients separately. Focus groups and interviews were audio recorded, transcribed verbatim and thematically analyzed. Data analysis was guided by the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework\",\"PeriodicalId\":9476,\"journal\":{\"name\":\"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada\",\"volume\":\"50 \",\"pages\":\"S1 - S45\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/17151635231219546\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17151635231219546","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:从 2023 年 1 月起,药剂师的执业范围将扩大到包括在社区药房开具十三种轻微疾病(包括传染病)的处方。这一扩展为改善患者获得及时护理的机会,以及利用药剂师的专业知识增加适当处方提供了机遇。确定有效实施药剂师处方的关键促进因素和障碍对于积极支持这一演变至关重要。目的:确定有效实施药剂师为特定轻微疾病和传染病开处方的促进因素和障碍 方法 :采用虚拟访谈和在线调查的方式,收集药剂师对安大略省各地在启动之前所提供服务的看法。分别与初级保健医生和患者进行了虚拟焦点小组讨论。对焦点小组和访谈进行了录音、逐字记录和主题分析。数据分析以实施研究综合框架 (CFIR) 和理论领域框架为指导
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
OPEN Summit 2023 Abstracts–Poster and Oral Presentations
BACKGROUND: Expanding pharmacists' scope of practice to include prescribing for thirteen minor ailments, including infectious diseases, in the community pharmacy setting began January 2023. This expansion presents opportunities to improve patients’ access to timely care and harness pharmacists’ expertise to increase appropriate prescribing. Identifying key facilitators and barriers for the effective implementation of pharmacist prescribing is crucial to proactively support this evolution. OBJECTIVE : To identify facilitators and barriers for the effective implementation of pharmacists prescribing medications for selected minor ailments and infectious diseases METHODS : Virtual interviews and online surveys were utilized to gather pharmacists’ perspectives on service provision across Ontario prior to the launch. Virtual focus group discussions were conducted with primary care physicians and patients separately. Focus groups and interviews were audio recorded, transcribed verbatim and thematically analyzed. Data analysis was guided by the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Congratulations to our 2024 CPhA award winners! Accessibility reality check Make your mark! Become a CPS author or reviewer Review of the top nephrology studies of 2020-2023 Harmonizing leadership: Blending transactional and transformational styles in pharmacy practice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1